FSNUY — Fresenius SE & Co. KGaA
—
OTC ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 904868 ·
Last close
$13.28
Market Cap
$29.92B
52W High
$33.01
52W Low
$10.33
ADV30
83,563
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 5,945,000,000 | 1,550,000,000 | 632,000,000 | 382,000,000 | 41,844,000,000 | 1,279,000,000 | 21,445,000,000 |
| Mar 2026 | 5,818,000,000 | 1,534,000,000 | 601,000,000 | 435,000,000 | 42,370,000,000 | 2,059,000,000 | 21,905,000,000 |
| Dec 2025 | 6,156,000,000 | 1,524,000,000 | 468,400,000 | 361,000,000 | 41,395,000,000 | 1,307,000,000 | 21,628,000,000 |
| Sep 2025 | — | — | — | — | — | — | — |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$2,207,000,000
Investing CF
$-512,000,000
Financing CF
$-3,035,000,000
CapEx
$-1,311,000,000
Dividends Paid
$-656,000,000
Buybacks
—
EPS Diluted TTM
$0.44
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
—
Inventory
$2,730,000,000
Receivables
—
ST Investments
$1,890,000,000
EBIT TTM
$2,770,000,000
Pretax Income TTM
$2,289,000,000
Interest Exp TTM
—
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$23,281,000,448
EBITDA
$3,039,000,064
Free Cash Flow
$1,710,125,056
Enterprise Value
$40,331,104,256
Total Cash
$1,279,000,064
Total Debt
$11,418,999,808
Shares Out
2,252,949,108
Trailing EPS
$0.81
Book Value
$10.14
ROE
8.3%
ROA
3.4%
Div Yield
2.33%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 22,873,000,000 | 2,181,400,000 | 1,264,000,000 | 41,395,000,000 | 21,628,000,000 | 19,104,000,000 | 2,574,000,000 |
| Dec 2024 | 21,954,000,000 | 2,073,000,000 | 471,000,000 | 43,550,000,000 | 23,260,000,000 | 19,542,000,000 | 2,447,000,000 |
| Dec 2023 | 21,067,000,000 | 1,183,000,000 | -594,000,000 | 45,284,000,000 | 25,633,000,000 | 18,999,000,000 | 4,456,000,000 |
| Dec 2022 | 21,532,000,000 | 1,812,000,000 | 1,372,000,000 | 76,400,000,000 | 44,182,000,000 | 20,415,000,000 | 4,198,000,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$2.89
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| GEHC | GE HealthCare Technologies Inc. | $30.10B | $66.63 | — |
| MDLN | Medline Inc. | $30.44B | $34.70 | — |
| FSNUF | Fresenius SE & Co. KGaA | $30.61B | $54.35 | — |
| RMD | RESMED INC | $32.02B | $222.00 | — |
| DXCM | DEXCOM INC | $32.69B | $86.62 | — |
News headlines (Yahoo Finance, 1h cache)
All You Need to Know About Fresenius SE & Co. (FSNUY) Rating Upgrade to Buy
2026-09-07 16:00 · Yahoo
Are Investors Undervaluing Fresenius SE & Co. (FSNUY) Right Now?
2026-08-11 13:40 · Yahoo
Chemed (CHE) Tops Q2 Earnings and Revenue Estimates
2026-07-28 22:00 · Yahoo
Ensign Group (ENSG) Q2 Earnings and Revenues Top Estimates
2026-07-27 11:15 · Yahoo
Fresenius establishes venture fund of more than €200 million to drive healthcare innovation
2026-07-23 09:15 · Yahoo
Should Value Investors Buy Fresenius SE & Co. (FSNUY) Stock?
2026-06-15 13:40 · Yahoo
mAbxience and Sandoz Sign a Collaboration Agreement to Advance Biosimilar Access Worldwide
2026-09-18 10:28 · Yahoo
Fresenius SE & Co KGaA (FSNUY) (Q2 2026) Earnings Call Highlights: Raises Full-Year EPS ...
2026-08-05 19:04 · Yahoo
Hikma and Fresenius best positioned from Trump's generic drug tariffs, says Citi
2026-07-23 12:17 · Yahoo
European Equities Traded in the US as American Depositary Receipts Higher Wednesday
2026-02-18 16:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.